 Growth-inhibitory effect combination chemotherapy human pancreatic cancer cell lines Sensitivities anti-tumor drugs mitomycin MMC aclarubicin hydrochloride ACR doxorubicin hydrochloride ADR cisplatin cell lines human pancreatic cancer cell lines different sensitivities anti-tumor drugs concentrations growth-inhibition hours exposure micrograms/ml MMC micrograms/ml ACR micrograms/ml ADR micrograms/ml cisplatin micrograms/ml anti-tumor drug hours exposure combination MMC ACR synergistic inhibition growth cell lines results MMC ACR ADR cisplatin sufficient anti-tumor effect human pancreatic cancer cell lines achievable concentrations exposure times chemotherapy pancreatic cancers effective drug delivery cancer tissues